MycoBiomDB – Record Details (MyCo_1329)

Biomarker Record Details

Database ID: MyCo_1329
DB IDMyCo_1329
TitleClinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients
Year2011
PMID21388550
Fungal Diseases involvedInvasive candidiasis
Associated Medical Conditionsurgical patients admitted in ICU
GenusCandida
Speciesalbicans
OrganismCandida albicans
Ethical StatementThe institutional review boards at each participating institution approved the study and informed consent was obtained in each patient included in the study.
Site of InfectionNone
Opportunistic invasiveInvasive
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameCAGTA
Biomarker Full NameCandida albicans Germ Tube Antibody (CAGTA)
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationSpain
CohortFifty-three miscellaneous critically ill patients were included in the study, 37.7% of whom needed surgical procedure during their stay in the ICU.
Cohort No.53
Age GroupNone
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismInvasive candidiasis (IC), especially in the critical care setting, has become an excellent target for prophylactic, empiric, and pre-emptive therapy interventions due to its increased incidence, high morbidity, mortality rate, and associated healthcare costs. Although the past few years have brought exciting developments in anti- fungal pharmacotherapy, the mortality rate remains excessively high.
TechniqueImmunological assay
Analysis MethodCAGTA Immunofluorescence test Kit (Vircell Microbiologist S.L., Granada, Spain)
ELISA kitsCAGTA Immunofluorescence test Kit (Vircell Microbiologist S.L., Granada, Spain)
Assay DataNone
Validation Techniques usedCAGTA Immunofluorescence Analysis
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone